Balaji Amines Q1 Results: EBITDA Doubles, Net Profit Jumps 81% YoY
Balaji Amines posted strong Q1 results with consolidated net profit rising 81% YoY to ₹781 million and revenue growing 27% to ₹4.56 billion. EBITDA more than doubled to ₹1.16 billion from ₹547 million, with EBITDA margin expanding sharply to 25.41% from 15.26% YoY, reflecting significant operating leverage and improved cost management.

*this image is generated using AI for illustrative purposes only.
Balaji Amines reported a strong quarterly performance with consolidated net profit rising 81% year-on-year to ₹781 million, driven by robust volume growth and significant margin expansion across its core amines business. Revenue from operations grew 27% year-on-year to ₹4.56 billion from ₹3.58 billion in the same period last year. Standalone net profit also surged to ₹721.4 lakh, up 81% from ₹523.4 lakh in profit before tax in the prior year period, reflecting broad-based operational improvement.
The Board of Directors approved the unaudited standalone and consolidated financial results on July 27, 2026, in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Statutory Auditors M/s. M. Anandam & Co., Chartered Accountants, issued limited review reports on the financial statements. The results were prepared in accordance with Indian Accounting Standards (Ind AS) prescribed under Section 133 of the Companies Act, 2013.
Financial Performance
The company's consolidated financials reflect strong operational leverage, with profitability growing at a significantly faster pace than revenue. EBITDA more than doubled to ₹1.16 billion from ₹547 million in the year-ago period, while EBITDA margin expanded sharply to 25.41% from 15.26%, highlighting meaningful improvement in cost efficiency and product mix. The following table summarises key consolidated financial metrics:
| Metric | Q1FY27 | Q1FY26 | Change |
|---|---|---|---|
| Revenue from Operations | ₹4.56B | ₹3.58B | +27% |
| EBITDA | ₹1.16B | ₹547M | +112% |
| EBITDA Margin | 25.41% | 15.26% | +1015 bps |
| Profit Before Tax | ₹1,062.0 lakh | ₹490.1 lakh | +117% |
| Net Profit (Consolidated) | ₹781M | ₹380M | +106% |
| EPS (Basic) | ₹23.13 | ₹11.73 | +97% |
Standalone revenue from operations was ₹4,227.4 lakh, up from ₹3,193.8 lakh in Q1FY26. Standalone profit before tax rose to ₹978.2 lakh from ₹523.4 lakh. Standalone net profit was ₹721.4 lakh, with basic earnings per share at ₹22.27, compared to ₹12.28 in the previous year. Total consolidated income reached ₹4,614.5 lakh, with tax expenses of ₹2,808.6 lakh recorded for the period.
Segment Analysis
The Amines & Speciality Chemicals segment remained the primary growth driver, contributing ₹4,528.9 lakh to segment revenue, up from ₹3,573.7 lakh in Q1FY26. Segment result before tax and interest for this division was ₹1,054.5 lakh, compared to ₹454.4 lakh in the corresponding period last year. The Hotel Division generated ₹79.9 lakh in revenue, down from ₹102.7 lakh, with a segment result of ₹16.0 lakh. Inter-segment revenue was ₹6.7 lakh, and the consolidated results include the subsidiary Balaji Speciality Chemicals Limited.
Total segment assets stood at ₹2,667.2 crore, while segment liabilities were ₹437.4 crore. The disproportionate growth in profit before tax (117%) relative to revenue growth (27%) indicates significant operating leverage. Cost of materials consumed rose to ₹2,460.9 lakh from ₹1,662.5 lakh, but employee benefits and other expenses remained relatively stable as a percentage of revenue, supporting the sharp EBITDA margin expansion observed in the quarter.
Historical Stock Returns for Balaji Amines
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +5.07% | -0.19% | +10.03% | +99.13% | +31.19% | -29.79% |
Will the sharp EBITDA margin expansion to 25.41% be sustainable in Q2FY27 given potential volatility in raw material costs for amines?
How does the company plan to capitalize on this profitability surge through capital expenditure or capacity expansion in the coming fiscal year?
What specific product mix shifts or pricing power dynamics contributed most to the 1015 bps improvement in EBITDA margins?


































